Global Antibody-drug Conjugates Market Research Report 2021
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Research Predicts that Antibody-drug Conjugates Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.
Global Antibody-drug Conjugates Market Overview:
Global Antibody-drug Conjugates Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Antibody-drug Conjugates involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Impact of COVID-19 on Antibody-drug Conjugates Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Antibody-drug Conjugates market in 2020.
Global Antibody-drug Conjugates Market Segmentation
By Type, Antibody-drug Conjugates market has been segmented into:
Adcetris
Kadcyla
By Application, Antibody-drug Conjugates market has been segmented into:
Breast Cancer
Lymphoma
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Top Key Players Covered in Antibody-drug Conjugates market are:
ImmunoGen
Seattle Genetics
Roche
Takeda
1. Market Overview of Antibody-drug Conjugates
1.1 Antibody-drug Conjugates Market Overview
1.1.1 Antibody-drug Conjugates Product Scope
1.1.2 Market Status and Outlook
1.2 Antibody-drug Conjugates Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Antibody-drug Conjugates Historic Market Size by Regions (2015-2020)
1.4 Antibody-drug Conjugates Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Antibody-drug Conjugates Sales Market by Type (2015-2026)
2.1 Global Antibody-drug Conjugates Historic Market Size by Type (2015-2020)
2.2 Global Antibody-drug Conjugates Forecasted Market Size by Type (2021-2026)
2.3 Adcetris
2.4 Kadcyla
3. Covid-19 Impact Antibody-drug Conjugates Sales Market by Application (2015-2026)
3.1 Global Antibody-drug Conjugates Historic Market Size by Application (2015-2020)
3.2 Global Antibody-drug Conjugates Forecasted Market Size by Application (2021-2026)
3.3 Breast Cancer
3.4 Lymphoma
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Antibody-drug Conjugates Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global Antibody-drug Conjugates Revenue Market Share by Manufacturers (2015-2020)
4.3 Global Antibody-drug Conjugates Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in Antibody-drug Conjugates Business
5.1 ImmunoGen
5.1.1 ImmunoGen Company Profile
5.1.2 ImmunoGen Antibody-drug Conjugates Product Specification
5.1.3 ImmunoGen Antibody-drug Conjugates Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 Seattle Genetics
5.2.1 Seattle Genetics Company Profile
5.2.2 Seattle Genetics Antibody-drug Conjugates Product Specification
5.2.3 Seattle Genetics Antibody-drug Conjugates Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 Roche
5.3.1 Roche Company Profile
5.3.2 Roche Antibody-drug Conjugates Product Specification
5.3.3 Roche Antibody-drug Conjugates Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 Takeda
5.4.1 Takeda Company Profile
5.4.2 Takeda Antibody-drug Conjugates Product Specification
5.4.3 Takeda Antibody-drug Conjugates Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America Antibody-drug Conjugates Market Size (2015-2026)
6.2 North America Antibody-drug Conjugates Key Players in North America (2015-2020)
6.3 North America Antibody-drug Conjugates Market Size by Type (2015-2020)
6.4 North America Antibody-drug Conjugates Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia Antibody-drug Conjugates Market Size (2015-2026)
7.2 East Asia Antibody-drug Conjugates Key Players in North America (2015-2020)
7.3 East Asia Antibody-drug Conjugates Market Size by Type (2015-2020)
7.4 East Asia Antibody-drug Conjugates Market Size by Application (2015-2020)
8. Europe
8.1 Europe Antibody-drug Conjugates Market Size (2015-2026)
8.2 Europe Antibody-drug Conjugates Key Players in North America (2015-2020)
8.3 Europe Antibody-drug Conjugates Market Size by Type (2015-2020)
8.4 Europe Antibody-drug Conjugates Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia Antibody-drug Conjugates Market Size (2015-2026)
9.2 South Asia Antibody-drug Conjugates Key Players in North America (2015-2020)
9.3 South Asia Antibody-drug Conjugates Market Size by Type (2015-2020)
9.4 South Asia Antibody-drug Conjugates Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia Antibody-drug Conjugates Market Size (2015-2026)
10.2 Southeast Asia Antibody-drug Conjugates Key Players in North America (2015-2020)
10.3 Southeast Asia Antibody-drug Conjugates Market Size by Type (2015-2020)
10.4 Southeast Asia Antibody-drug Conjugates Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East Antibody-drug Conjugates Market Size (2015-2026)
11.2 Middle East Antibody-drug Conjugates Key Players in North America (2015-2020)
11.3 Middle East Antibody-drug Conjugates Market Size by Type (2015-2020)
11.4 Middle East Antibody-drug Conjugates Market Size by Application (2015-2020)
12. Africa
12.1 Africa Antibody-drug Conjugates Market Size (2015-2026)
12.2 Africa Antibody-drug Conjugates Key Players in North America (2015-2020)
12.3 Africa Antibody-drug Conjugates Market Size by Type (2015-2020)
12.4 Africa Antibody-drug Conjugates Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania Antibody-drug Conjugates Market Size (2015-2026)
13.2 Oceania Antibody-drug Conjugates Key Players in North America (2015-2020)
13.3 Oceania Antibody-drug Conjugates Market Size by Type (2015-2020)
13.4 Oceania Antibody-drug Conjugates Market Size by Application (2015-2020)
14. South America
14.1 South America Antibody-drug Conjugates Market Size (2015-2026)
14.2 South America Antibody-drug Conjugates Key Players in North America (2015-2020)
14.3 South America Antibody-drug Conjugates Market Size by Type (2015-2020)
14.4 South America Antibody-drug Conjugates Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World Antibody-drug Conjugates Market Size (2015-2026)
15.2 Rest of the World Antibody-drug Conjugates Key Players in North America (2015-2020)
15.3 Rest of the World Antibody-drug Conjugates Market Size by Type (2015-2020)
15.4 Rest of the World Antibody-drug Conjugates Market Size by Application (2015-2020)
16 Antibody-drug Conjugates Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter’s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Research Methodology:
Antibody drug Conjugates Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|